Your browser doesn't support javascript.
Inferring the true number of SARS-CoV-2 infections in Japan.
McKenzie, Lauren; Shoukat, Affan; Wong, Kai On; Itahashi, Koju; Yasuda, Eiji; Demarsh, Alex; Khan, Kamran.
  • McKenzie L; BlueDot, Toronto, Ontario, Canada.
  • Shoukat A; BlueDot, Toronto, Ontario, Canada; Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada. Electronic address: affansm@yorku.ca.
  • Wong KO; BlueDot, Toronto, Ontario, Canada.
  • Itahashi K; Medical Affairs Department, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan.
  • Yasuda E; Digital Transformation Sect., Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan.
  • Demarsh A; BlueDot, Toronto, Ontario, Canada.
  • Khan K; BlueDot, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
J Infect Chemother ; 28(11): 1519-1522, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2036256
ABSTRACT

INTRODUCTION:

In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities.

METHODS:

We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions.

RESULTS:

We estimated that as of December 31, 2021, 3.07 million (CrI 2.05-4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan.

CONCLUSIONS:

We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Reviews Topics: Vaccines / Variants Limits: Adult / Humans Country/Region as subject: Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: J.jiac.2022.08.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Reviews Topics: Vaccines / Variants Limits: Adult / Humans Country/Region as subject: Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: J.jiac.2022.08.002